MARKET

NITO

NITO

N2OFF INC
NASDAQ
0.9736
-0.0464
-4.55%
Opening 15:59 02/11 EST
OPEN
1.020
PREV CLOSE
1.020
HIGH
1.040
LOW
0.9736
VOLUME
32.94K
TURNOVER
--
52 WEEK HIGH
41.65
52 WEEK LOW
0.8756
MARKET CAP
2.70M
P/E (TTM)
-0.0762
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NITO last week (0202-0206)?
Weekly Report · 2d ago
N2OFF highlights research on mitochondrial carriers in spaceflight conditions
TipRanks · 02/02 13:20
MitoCareX Bio Advances Mitochondrial Drug Research Under N2OFF Inc
Reuters · 02/02 13:05
Weekly Report: what happened at NITO last week (0126-0130)?
Weekly Report · 02/02 09:38
In Spaceflight Conditions: N2OFF‘s MitoCareX Bio Highlights Co-Founder's Innovative Research on Mitochondrial Carriers in Microgravity and Cosmic radiation Conditions
Barchart · 02/02 07:05
Weekly Report: what happened at NITO last week (0119-0123)?
Weekly Report · 01/26 09:38
N2OFF announces MitoCareX Bio has shown preliminary in vitro data on platform
TipRanks · 01/22 12:42
N2OFF Says MitoCareX Bio Shows Preliminary In Vitro Data Demonstrating Inhibition Of Pro‑Inflammatory Responses In Human Immune Cells Using Its Proprietary Discovery Platform
Benzinga · 01/22 12:36
More
About NITO
N2OFF, Inc. is a cleantech company mainly engaged in European Union (EU) based solar assets using the Ready to Build (RTB) business model. The Company is an investor in four solar projects in three different EU countries. It collaborates with Solterra Renewable Energy Ltd., an Israeli corporation and a wholly owned subsidiary of Solterra Energy Ltd., an Israeli corporation, which operates in the solar energy sector and presents certain investment opportunities in solar photovoltaic (PV) projects. The Company also controls approximately 98% of Save Foods Ltd., an Israeli company focused on post-harvest treatments in fruit and vegetables to control and prevent pathogen contamination. The Company’s solutions are focused on improving the food safety and shelf life of fresh produce. The Company, through its subsidiary, MitoCareX Bio Ltd., is focused on the development of novel therapies for hard-to-treat cancers by targeting proteins belonging to the mitochondrial SLC25 protein family.

Webull offers N2OFF Inc stock information, including NASDAQ: NITO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NITO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NITO stock methods without spending real money on the virtual paper trading platform.